Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
success crawled date : 2021 - 11 - 22 save search
Matterport Announces Successful Completion of SOC 2 Type II Audit
Published: 2021-11-22 (Crawled : 14:30) - globenewswire.com
MTTR | News 4 | $4.645 0.98% 0.97% 10M
|
|
| O: 3.98%
H: 2.86%
C: -10.08%
Zealand Pharma announces successful outcome of Phase 1b clinical trial with GLP1-GLP2 dual receptor agonist, dapiglutide
Published: 2021-11-22 (Crawled : 14:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
|
| O: -3.5%
H: 1.43%
C: -4.88%
phase 1 phase 1b trial phase 2b
Evofem Biosciences Successfully Extends Cumulative Net Sales Covenant Timing to June 30, 2023
Published: 2021-11-22 (Crawled : 12:00) - prnewswire.com
EVFM | $0.0128 -16.94% 1.9M
|
Health Technology
|
| O: 8.89%
H: 2.29%
C: -1.8%
sales bioscience
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.